Loading...
HGF/c-MET抑制剂治疗非小细胞肺癌的研究进展
Molecular targeted therapy has become more and more important in the treatment of non-small cell lung cancer (NSCLC). HGF/c-MET plays the pivotal role in the growth, development and tolerance to epidermal growth factor receptor tyrosine kinase inhibitor of NSCLC. Moreover it has become another heat...
Saved in:
| Published in: | Zhongguo Fei Ai Za Zhi |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
中国肺癌杂志编辑部
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6000280/ https://ncbi.nlm.nih.gov/pubmed/25936889 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2015.04.09 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|